Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management

Dermatology and Therapy(2021)10.1007/s13555-021-00624-7Source: DataRank Database

Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management is a research paper published in Dermatology and Therapy (2021). On theSindex it has a DataRank of 0. It has been cited 44 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access44 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (11)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Kerri E. Rieger ORCID,M. Bagot ORCID,Jennifer Choi ORCID,David C. Fisher ORCID,Joan Guitart ORCID

Live enrichment

PubMed:19162232

NIH/NCI Cancer Center Support Grant

Grant: P30 CA008748

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

Grant: 1U01AR077511-01

Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy

goldLicense: cc-by-nc

publisherhttps://link.springer.com/content/pdf/10.1007/s13555-021-00624-7.pdf

publisherhttps://link.springer.com/article/10.1007/s13555-021-00624-7/fulltext.html

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8776934

repositoryhttps://digitalcommons.wustl.edu/oa_4/3332

repositoryhttp://hdl.handle.net/1887/3589626

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

Mycosis fungoidesCutaneous T-cell lymphomaEruptionRashICTS (Institute of Clinical and Translational Sciences)Medicine and Health SciencesMogamulizumabReviewSezary syndrome

Sustainable Development Goals

SDG 3: 3. Good health

Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management

10.6084/m9.figshare.16677523.v1Adis Journals

Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management

10.6084/m9.figshare.16677523Adis Journals